• Tibbiyot
  • 28 iyul
  • FDA approves Outlook Therapeutics' ONS-5010
    2
  • 31 iyul
  • Cyclosporiasis cases in U.S. by July 31
    10
  • 30 dekabr
  • CDC to issue Level 4 warning by December 31
    2
  • FDA approves Retatrutide this year
    2
  • FDA to approve Daraxonrasib this year
    2